S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
Log in

NASDAQ:ICUI - ICU Medical Stock Price, Forecast & News

$196.87
+9.20 (+4.90 %)
(As of 03/30/2020 04:00 PM ET)
Today's Range
$185.38
Now: $196.87
$197.68
50-Day Range
$160.04
MA: $195.98
$216.15
52-Week Range
$148.89
Now: $196.87
$259.72
Volume126,121 shs
Average Volume158,664 shs
Market Capitalization$4.09 billion
P/E Ratio41.89
Dividend YieldN/A
Beta0.75
ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation/urologics, such as sodium chloride irrigation, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. Further, it provides ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Read More
ICU Medical logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ICUI
CUSIP44930G10
Phone949-366-2183

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.27 billion
Cash Flow$12.38 per share
Book Value$66.62 per share

Profitability

Net Income$101.04 million

Miscellaneous

Employees8,000
Market Cap$4.09 billion
Next Earnings Date5/14/2020 (Estimated)
OptionableOptionable

Receive ICUI News and Ratings via Email

Sign-up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.


ICU Medical (NASDAQ:ICUI) Frequently Asked Questions

How has ICU Medical's stock been impacted by COVID-19 (Coronavirus)?

ICU Medical's stock was trading at $180.56 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ICUI shares have increased by 9.0% and is now trading at $196.87. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of ICU Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for ICU Medical.

When is ICU Medical's next earnings date?

ICU Medical is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for ICU Medical.

How were ICU Medical's earnings last quarter?

ICU Medical, Incorporated (NASDAQ:ICUI) released its quarterly earnings results on Thursday, February, 27th. The medical instruments supplier reported $1.94 EPS for the quarter, beating the Zacks' consensus estimate of $1.63 by $0.31. The medical instruments supplier had revenue of $315.50 million for the quarter, compared to analyst estimates of $302.85 million. ICU Medical had a return on equity of 11.92% and a net margin of 7.98%. The firm's revenue for the quarter was down 7.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.07 EPS. View ICU Medical's earnings history.

What guidance has ICU Medical issued on next quarter's earnings?

ICU Medical issued an update on its FY20 earnings guidance on Thursday, February, 27th. The company provided earnings per share guidance of $6.50-7.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.21.

What price target have analysts set for ICUI?

2 brokers have issued 1 year target prices for ICU Medical's shares. Their forecasts range from $206.00 to $215.00. On average, they anticipate ICU Medical's stock price to reach $210.50 in the next twelve months. This suggests a possible upside of 6.9% from the stock's current price. View analysts' price targets for ICU Medical.

Has ICU Medical been receiving favorable news coverage?

Press coverage about ICUI stock has been trending very positive this week, InfoTrie reports. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. ICU Medical earned a media sentiment score of 4.0 on InfoTrie's scale. They also gave media coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutICU Medical.

Are investors shorting ICU Medical?

ICU Medical saw a decline in short interest during the month of March. As of March 13th, there was short interest totaling 644,800 shares, a decline of 6.7% from the February 27th total of 691,400 shares. Based on an average daily trading volume, of 156,800 shares, the short-interest ratio is presently 4.1 days. Currently, 3.3% of the company's shares are sold short. View ICU Medical's Current Options Chain.

Who are some of ICU Medical's key competitors?

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton Dickinson and (BDX), BlackRock (BLK), CA (CA), Alibaba Group (BABA), UnitedHealth Group (UNH), Endologix (ELGX), Chipotle Mexican Grill (CMG), Netflix (NFLX), NVIDIA (NVDA) and Boeing (BA).

Who are ICU Medical's key executives?

ICU Medical's management team includes the following people:
  • Mr. Vivek Jain, Chairman & CEO (Age 47)
  • Mr. Scott E. Lamb, CFO & Treasurer (Age 56)
  • Mr. Christian B. Voigtlander, Chief Operating Officer (Age 51)
  • Ms. Virginia Ruth Sanzone, Corp. VP, Gen. Counsel & Sec. (Age 44)
  • Mr. Thomas D. McCall, Corp. VP of Marketing & Communications and GM of Critical Care (Age 61)

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Nuance Investments LLC (3.61%), State Street Corp (2.43%), Nitorum Capital L.P. (2.22%), Point72 Asset Management L.P. (2.20%), Victory Capital Management Inc. (1.87%) and Victory Capital Management Inc. (1.85%). Company insiders that own ICU Medical stock include Alison D Burcar, Christian B Voigtlander, Daniel Woolson, George A Lopez, Joseph R Saucedo, Kevin J Mcgrody, Pfizer Inc, Robert S Swinney, Scott E Lamb, Thomas D Mccall and Virginia Ruth Sanzone. View institutional ownership trends for ICU Medical.

Which institutional investors are selling ICU Medical stock?

ICUI stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Public Employees Retirement Association of Colorado, Raymond James Financial Services Advisors Inc., Raymond James & Associates, Bank of Montreal Can, AQR Capital Management LLC, Cubist Systematic Strategies LLC, and Kennedy Capital Management Inc.. Company insiders that have sold ICU Medical company stock in the last year include Christian B Voigtlander, George A Lopez, Kevin J Mcgrody, Robert S Swinney, Scott E Lamb, and Virginia Ruth Sanzone. View insider buying and selling activity for ICU Medical.

Which institutional investors are buying ICU Medical stock?

ICUI stock was purchased by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Norges Bank, Partner Fund Management L.P., Nuance Investments LLC, Victory Capital Management Inc., Victory Capital Management Inc., Jacobs Levy Equity Management Inc., and Tamarack Advisers LP. View insider buying and selling activity for ICU Medical.

How do I buy shares of ICU Medical?

Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $196.87.

How big of a company is ICU Medical?

ICU Medical has a market capitalization of $4.09 billion and generates $1.27 billion in revenue each year. The medical instruments supplier earns $101.04 million in net income (profit) each year or $7.36 on an earnings per share basis. ICU Medical employs 8,000 workers across the globe. View additional information about ICU Medical.

What is ICU Medical's official website?

The official website for ICU Medical is http://www.icumed.com/.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at 949-366-2183 or via email at [email protected]


MarketBeat Community Rating for ICU Medical (NASDAQ ICUI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  348 (Vote Outperform)
Underperform Votes:  351 (Vote Underperform)
Total Votes:  699
MarketBeat's community ratings are surveys of what our community members think about ICU Medical and other stocks. Vote "Outperform" if you believe ICUI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICUI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/30/2020 by MarketBeat.com Staff

Featured Article: Resistance Level

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel